Efficacy of superior hypogastric plexus block with bupivacaine 0.5% for post total abdominal hysterectomy pain relief
Swidan, E., Abdelzaam, E. (2017). Efficacy of superior hypogastric plexus block with bupivacaine 0.5% for post total abdominal hysterectomy pain relief. EKB Journal Management System, 21(1), 23-29. doi: 10.21608/egyfs.2017.19522
Ebrahem Swidan; Elsayed Abdelzaam. "Efficacy of superior hypogastric plexus block with bupivacaine 0.5% for post total abdominal hysterectomy pain relief". EKB Journal Management System, 21, 1, 2017, 23-29. doi: 10.21608/egyfs.2017.19522
Swidan, E., Abdelzaam, E. (2017). 'Efficacy of superior hypogastric plexus block with bupivacaine 0.5% for post total abdominal hysterectomy pain relief', EKB Journal Management System, 21(1), pp. 23-29. doi: 10.21608/egyfs.2017.19522
Swidan, E., Abdelzaam, E. Efficacy of superior hypogastric plexus block with bupivacaine 0.5% for post total abdominal hysterectomy pain relief. EKB Journal Management System, 2017; 21(1): 23-29. doi: 10.21608/egyfs.2017.19522

Efficacy of superior hypogastric plexus block with bupivacaine 0.5% for post total abdominal hysterectomy pain relief

The Egyptian Journal of Fertility of Sterility
Article 10, Volume 21, Issue 1, January 2017, Page 23-29  XML PDF (2.67 MB)
Document Type: Original Article
DOI: 10.21608/egyfs.2017.19522
View on SCiNiTO View on SCiNiTO
Authors
Ebrahem Swidan1; Elsayed Abdelzaam2
1Lecturer of obstetrics and Gynecology Department, Benha University Hospital, Benha University Egypt.
2Lecturer of Anesthesia & I.C.U, Benha University Hospital, Benha University Egypt.
Abstract
Aim: To evaluate the analgesic effect of superior hypogastric plexus (SHP) area infiltration with 20 ml bupivacaine0.5% on post total abdominal hysterectomy (TAH) pain. Patients and Methods: This a prospective randomized, double blind, placebo controlled study, conducted at Benha University Hospital, including sixty women undergoin TAH, thirty women received 20 ml bupivacaine 0.5% and thirty women received 20 ml saline infiltrated in SHP area at end of TAH. Main outcomes measures were total cumulative Nalbuphine consumption and post TAH pain using visual analogue scale (VAS), as well as nausea, vomiting, other analgesic requirements, time spent in post anaesthesia care unit (PACU), time to get out of bed. Results: The mean post TAH pain VAS score at PACU, two, six hours postoperatively were significantly lower in bupivacaine group (P = 0.016, P = 0.0006, P = 0.0008). Total Nalbuphine consumption were significantly lower in bupivacaine group at six, twenty four hours, postoperatively and at discharge (P < 0.0001, P < 0.0001, P < 0.0001). Also total nonsteroidal anti-inflammatory drugs (NSAIDs) consumption were lower in bupivacaine at twenty four hours postoperatively as well as at discharge (P < 0.0001, P = 0.0006), nausea, vomiting, and time to first flatus were significantly lower in bupivacaine group (P = 0.02, P = 0.02, P = 0.0068). Conclusion: Post TAH infiltration of SHP area with 20 ml bupivacaine 0.5% reduce postoperative pain and total cumulative opioid and NSAIDs analgesics as well as promotes early gut recovery after TAH.
Keywords
Total Abdominal Hysterectomy; visual analogue score; Bupivacaine; local anaesthesia; opioids consumption
Statistics
Article View: 197
PDF Download: 550